Showing 601 - 620 results of 926 for search '"Lung cancer"', query time: 0.09s Refine Results
  1. 601

    The Effect of the Concurrent Use of Angiotensin-Converting Enzyme Inhibitors or Receptor Blockers on Toxicity and Outcomes in Patients Treated with Radiotherapy: A Systematic Revie... by Wan-Chuen Liao, Hala Shokr, Corinne Faivre-Finn, Clare Dempsey, Kaye Janine Williams, Li-Chia Chen

    Published 2025-01-01
    “…Among six studies reporting survival, ACEI/ARB users had longer median survival in early-stage non-small-cell lung cancer and glioblastoma but shorter survival in small cell lung cancer and brain metastases. …”
    Get full text
    Article
  2. 602

    EGFR-Mutant Lung Adenocarcinoma Mimicking a Pneumonia by Álvaro Taus, Flavio Zuccarino, Carlos Trampal, Edurne Arriola

    Published 2012-01-01
    “…PET-CT scan has demonstrated to be very effective in lung cancer diagnosis and staging, but lung cancer has multiple ways of presentation, which can lead to an error in diagnosis imaging and a delay on the beginning of specific treatment. …”
    Get full text
    Article
  3. 603

    Successful Treatment of Crizotinib-Induced Fulminant Liver Failure: A Case Report and Review of Literature by Kyle Kreitman, Satheesh P. Nair, Jiten P. Kothadia

    Published 2020-01-01
    “…Crizotinib is a first-line tyrosine kinase inhibitor used for the treatment of metastatic lung cancer. Crizotinib-induced hepatotoxicity is a rare event. …”
    Get full text
    Article
  4. 604

    Integrating representation learning, permutation, and optimization to detect lineage-related gene expression patterns by Hannah M. Schlüter, Caroline Uhler

    Published 2025-01-01
    “…We validate our method using synthetic data and apply it to recent paired lineage and scRNA-seq data of lung cancer in a mouse model and embryogenesis of mouse and C. elegans. …”
    Get full text
    Article
  5. 605

    Rectal Metastases from Squamous Cell Carcinoma: A Case Report and Review of the Literature by S. Cedrés, N. Mulet-Margalef, M. A. Montero, P. Martinez, A. Martínez, E. Felip

    Published 2012-01-01
    “…Non-small-cell lung cancer (NSCLC) represents 85% of lung cancer. The most frequent sites of distant metastasis are the liver, adrenal glands, bones and brain. …”
    Get full text
    Article
  6. 606

    Infective Complications of Endobronchial Ultrasound-Transbronchial Needle Aspiration (EBUS-TBNA) and Clinical Biomarkers: A Concise Review by Pinelopi Bosgana, Dimitrios Ampazis, Vasileios Vlachakos, Argyrios Tzouvelekis, Fotios Sampsonas

    Published 2025-01-01
    “…EBUS-TBNA is the most common interventional pulmonology procedure performed globally and remains the cornerstone of the diagnosis and staging not only of lung cancer but also for other neoplastic, inflammatory, and infective pathologies of the mediastinum. …”
    Get full text
    Article
  7. 607

    Cigarette-Smoke-Induced Dysregulation of MicroRNA Expression and Its Role in Lung Carcinogenesis by Rebecca Russ, Frank J. Slack

    Published 2012-01-01
    “…Better understanding of miRNA dysregulation may allow for improved biomonitoring and treatment regimens for lung cancer.…”
    Get full text
    Article
  8. 608

    Neoadjuvant anti-PD-1-based immunotherapy: evolving a new standard of care by Drew M Pardoll, Suzanne L Topalian

    Published 2025-01-01
    “…Neoadjuvant (presurgical) anti-programmed cell death protein-1 (PD-1)-based immunotherapy as a new approach to cancer treatment has been developing on an accelerated trajectory since the seminal clinical trial results from studies in lung cancer and melanoma were published in 2018. Groundbreaking regulatory approvals in triple-negative breast cancer, non-small cell lung cancer and melanoma will certainly be followed by additional approvals in other disease indications, as clinical and basic research are burgeoning globally in hundreds of clinical trials across dozens of cancer types. …”
    Get full text
    Article
  9. 609

    Case report: Personalized management of treatment resistance in advanced NSCLC patients with mutated epidermal growth factor receptor: special examples and literature review by Jun Wang, Jun Wang, Xiaojing Li, Shuang Dong, Sheng Hu, Fengming Ran, Yu Qian

    Published 2025-02-01
    “…Lastly, the third acquired mechanism pertains to histological transformation, such as the emergence of small cell lung cancer (SCLC) clones. The transformation of pathological types has brought great confusion to the clinical diagnosis and treatment process. …”
    Get full text
    Article
  10. 610

    Polysaccharide Fraction Isolated from <i>Saccharina japonica</i> Exhibits Anti-Cancer Effects Through Immunostimulating Activities by Min Seung Park, Seung-U Son, Tae Eun Kim, Se Hyun Shim, Bong-Keun Jang, Sunyoung Park, Kwang-Soon Shin

    Published 2025-01-01
    “…In a study involving Colon26-M3.1 carcinoma as a lung cancer model, both <i>p.i.v.</i> and <i>p.p.o.</i> exhibited significant anti-lung-cancer effects. …”
    Get full text
    Article
  11. 611

    Oncogenic RIT1 mutations confer ferroptosis vulnerability in lung adenocarcinoma by Ruilan Ma, Dian Yang, Peng Wang, Ziyi Zhang, Xuehong Zhang, Jialiang Song, Han Liu, Shuyan Liu, Yingqiu Zhang, Lijuan Zou

    Published 2025-02-01
    “…Hence, our study unravels a novel aspect of RIT1 mutations in lung cancer and suggests ferroptosis induction as a potential therapeutic strategy to treat lung cancer patients carrying RIT1 mutations.…”
    Get full text
    Article
  12. 612

    Colorectal Metastasis From Lung Adenocarcinoma With Initial Gastrointestinal Symptoms: A Case Report and Literature Review by Yu Xin, Dan Liu, Dan Zang, Yan Sun, Jun Chen

    Published 2025-01-01
    “…ABSTRACT Lung cancer (LC) is a malignant tumor with high morbidity and mortality. …”
    Get full text
    Article
  13. 613

    Prevalence and prognosis of malignancy in THSD7A-associated membranous nephropathy: a systematic literature review and clinical case study by Qianqian Xu, Jiayi Li, Yue Yang, Li Zhuo, Hongmei Gao, Shimin Jiang, Wenge Li

    Published 2024-12-01
    “…Notably, we detected positive THSD7A staining in both renal and lung cancer tissues in one patient with small cell lung cancer.Conclusions Patients with THSD7A-associated MN should undergo vigilant follow-up assessments, with a particular focus on actively seeking potential tumorigenic lesions to prevent misdiagnosis or oversight.…”
    Get full text
    Article
  14. 614

    Graphene Oxide as a Nanocarrier for Controlled Loading and Targeted Delivery of Typhonium giganteum Drugs by Xiaohua Gu, Rui Cao, Fu Li, Yan Li, Hongge Jia, Hui Yu

    Published 2018-01-01
    “…Such nanofibers are effective in inhibiting the proliferation of A549 lung cancer cells, and thus they have potential for replacing chemotherapy-based treatments of lung cancer. …”
    Get full text
    Article
  15. 615

    An Osteolytic Metastasis of Humerus from an Asymptomatic Squamous Cell Carcinoma of Lung: A Rare Clinical Entity by Anirban Das, Sudipta Pandit, Sibes k. Das, Sumitra Basuthakur, Somnath Das

    Published 2014-01-01
    “…Advanced lung cancer is complicated by skeletal metastases either due to direct extension from adjacent primaries or, more commonly, due to haematogenous dissemination of neoplastic cells. …”
    Get full text
    Article
  16. 616

    MCF-DTI: Multi-Scale Convolutional Local–Global Feature Fusion for Drug–Target Interaction Prediction by Jihong Wang, Ruijia He, Xiaodan Wang, Hongjian Li, Yulei Lu

    Published 2025-01-01
    “…Our case study demonstrates that our model effectively validated several known drug–target relationships in lung cancer and predicted the therapeutic potential of certain preclinical compounds in treating lung cancer. …”
    Get full text
    Article
  17. 617

    Smoking Cessation in Chinese Patients Undergoing Thoracic Surgery: A Multicenter Prospective Observational Study by Jianxing He, Dingpei Han, Kun Qian, Weijie Guan, Ge Zhang, Weiqing Lu, Hecheng Li, Xiuyi Zhi

    Published 2024-01-01
    “…Results Of the 276 enrolled patients, 213 (77.2%) were smokers and 63 (22.8%) were quitters; 76.4% were diagnosed with primary lung cancer. PCs occurred in 13.8% of patients, with similar proportions in smokers (14.1%) and quitters (12.7%). …”
    Get full text
    Article
  18. 618

    Clofarabine induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8+ T-cell antitumor activity via the non-canonical P53/STING pathway by Jing Chen, Jie Wu, Xiang Chen, Qian Tao, Nian Liu, Cong Peng, Can Lu, Qiuqiu Li

    Published 2025-02-01
    “…Clinical data sets were used to analyze the correlation between stimulator of interferon genes (STING)-NFκB signaling and immune infiltration.Results In this study, Clo significantly reduced the growth of melanoma and lung cancer cells. Furthermore, Clo treatment induced GSDME-mediated pyroptosis. …”
    Get full text
    Article
  19. 619

    Large Language Model Approach for Zero-Shot Information Extraction and Clustering of Japanese Radiology Reports: Algorithm Development and Validation by Yosuke Yamagishi, Yuta Nakamura, Shouhei Hanaoka, Osamu Abe

    Published 2025-01-01
    “…ObjectiveThis study aimed to develop and evaluate an algorithm that uses large language models (LLMs) to extract information from Japanese lung cancer radiology reports and perform clustering analysis. …”
    Get full text
    Article
  20. 620

    Disease-Specific Target Gene Expression Profiling of Molecular Imaging Probes: Database Development and Clinical Validation by Lawrence Wing-Chi Chan, Connie Hiu-Ching Ngo, Fengfeng Wang, Moss Y. Zhao, Mengying Zhao, Helen Ka-Wai Law, Sze Chuen Cesar Wong, Benjamin Yat-Ming Yung

    Published 2014-08-01
    “…The DIPP database was validated with a clinical positron emission tomography (PET) study on lung cancer and an in vitro study on neuroendocrine cancer. …”
    Get full text
    Article